A breast cancer patient died after a delay of nearly two years in informing her of her positive test results.
In October 2009 a woman had a mastectomy performed by a breast surgeon at a private breast clinic, and following this the surgeon sent the tissue for tests, Health Commissioner Anthony Hill said.
One of the tests was to determine the HER2 receptor status, which if positive indicates a type of cancer that tends to be more fast growing, and may respond to Herceptin, which targets HER2 positive cancer and is given in conjunction with chemotherapy.
In November the woman met with a radiation oncologist to discuss adjuvant therapy options, and at that time her HER2 result was unavailable, Mr Hill said.
The radiation oncologist advised the woman she had a very good prognosis and recommended radiation therapy, not chemotherapy.